|
Therapies for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIABC010801
|
$954,356
|
$238,589
|
Widemann, Brigitte
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIASC010373
|
$812,723
|
$121,908
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
|
ZIABC010015
|
$345,165
|
$69,033
|
Wang, Ji Ming
|
CCR (NCI)
|
|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
261200800001E-51
|
$238,204,440
|
$425
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIABC010806
|
$287,376
|
$86,213
|
Khan, Javed
|
CCR (NCI)
|
|
Sulfatide-reactive type II NKT cells: repertoire and function
|
5R01CA100660-08
|
$349,565
|
$349,565
|
Kumar, Vipin
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-22
|
$426,822
|
$4,268
|
LANGEVIN, ANNE-MARIE
|
UNIV OF TX HSC, SA
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIABC010958
|
$448,460
|
$22,423
|
Daar, Ira
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIABC010391
|
$539,792
|
$53,979
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIABC010390
|
$539,792
|
$26,990
|
Tessarollo, Lino
|
CCR (NCI)
|
|
RNA interference approach to dissect roles of notochord regulators
|
ZIABC011121
|
$87,373
|
$26,212
|
Mackem, Susan
|
CCR (NCI)
|
|
Research Training in Neuro-Oncology
|
5T32CA009574-25
|
$241,622
|
$60,406
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
|
5R01CA122617-07
|
$258,308
|
$258,308
|
MANNING, BRENDAN
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIABC010788
|
$463,931
|
$92,786
|
Thiele, Carol
|
CCR (NCI)
|
|
Radiological Physics Center
|
5U10CA010953-44
|
$2,388,541
|
$23,885
|
Followill, David
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Quality Assurance Review Center
|
5U10CA029511-33
|
$1,668,149
|
$16,681
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Protein Structure, Stability, and Amyloid Formation
|
ZIABC010440
|
$374,422
|
$26,210
|
Nussinov, Ruth
|
CCR (NCI)
|
|
Physiological and pathological functions of E3 ubiquitin ligases Smurfs
|
ZIABC011168
|
$468,402
|
$23,420
|
Zhang, Ying
|
CCR (NCI)
|
|
Pediatric Cancer, Family Conflict and Child Adjustment
|
5R01CA134794-03
|
$377,487
|
$94,372
|
KATZ, LYNN
|
UNIVERSITY OF WASHINGTON
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIABC010789
|
$463,931
|
$46,393
|
Thiele, Carol
|
CCR (NCI)
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-09
|
$216,434
|
$4,329
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
O6-Benzylguanine and Temozolomide Treatment in Pediatric Glioma Patients
|
ZIABC010590
|
$41,815
|
$6,272
|
Warren, Katherine
|
CCR (NCI)
|
|
North Central Cancer Treatment Group
|
5U10CA025224-33
|
$5,558,123
|
$166,744
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
3U54CA151880-03S1
|
$57,724
|
$3,463
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
5U54CA151880-03
|
$2,318,024
|
$139,081
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIABC011038
|
$1,067,266
|
$53,363
|
Linehan, William
|
CCR (NCI)
|
|
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
|
ZIABC010540
|
$169,182
|
$59,214
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Micro RNA Profiling in Pediatric Cancers
|
ZIABC011001
|
$95,792
|
$4,790
|
Khan, Javed
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIABC010006
|
$448,460
|
$44,846
|
Daar, Ira
|
CCR (NCI)
|
|
Mechanisms of ATM activation
|
5R01CA132813-04
|
$242,941
|
$242,941
|
PAULL, TANYA
|
UNIVERSITY OF TEXAS AUSTIN
|
|
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
|
ZIASC004002
|
$1,555,531
|
$62,221
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIABC010998
|
$785,495
|
$39,275
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIABC010539
|
$592,136
|
$59,214
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIASC010366
|
$191,584
|
$38,317
|
Khan, Javed
|
CCR (NCI)
|
|
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
|
7R01CA098730-09
|
$282,326
|
$282,326
|
ROSS, THEODORA
|
UNIV OF TX SW MED CTR-DALLAS
|
|
Gundersen Lutheran Proposal to Join the Community Clinical Oncology Program
|
5U10CA159950-02
|
$574,500
|
$5,745
|
Go, Ronald
|
GUNDERSEN LUTHERAN MEDICAL FOUNDATION
|
|
GHSU Minority-Based Community Clinical Oncology Program
|
2U10CA107586-09
|
$492,552
|
$4,926
|
JILLELLA, ANAND
|
GEORGIA HEALTH SCIENCES UNIVERSITY
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIABC005598
|
$640,240
|
$32,012
|
Gottesman, Michael
|
CCR (NCI)
|
|
FEN-1 and PCNA Complexes and Human Genome Stability
|
5R01CA081967-13
|
$340,683
|
$170,342
|
TAINER, JOHN
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy
|
ZIABC010709
|
$41,815
|
$4,181
|
Warren, Katherine
|
CCR (NCI)
|
|
Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom
|
1R01CA164295-01A1
|
$301,772
|
$150,886
|
Karajannis, Matthias
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
EORTC HEADQUARTERS
|
5U10CA011488-42
|
$235,448
|
$2,354
|
Lacombe, Denis
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
ECOG Statistical Office Data Management Grant
|
5U10CA066636-19
|
$2,588,632
|
$51,773
|
GRAY, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
ECOG Statistical Office
|
5U10CA023318-36
|
$2,311,793
|
$46,236
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
ECOG Clinical Trials
|
5U10CA017145-37
|
$415,756
|
$8,315
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
ECOG - ACRIN CCOP RESEARCH BASE GRANT - CORE
|
2U10CA037403-27
|
$4,068,148
|
$40,681
|
COMIS, ROBERT
|
Drexel University
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-38
|
$354,850
|
$7,097
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Eastern Cooperative Oncology Group Operations Office
|
5U10CA021115-38
|
$8,790,165
|
$175,803
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
|
5U10CA021076-37
|
$564,359
|
$11,287
|
Kahl, Brad
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Eastern Cooperative Oncology Group (Main Institution)
|
5U10CA039229-27
|
$227,742
|
$4,555
|
KIRKWOOD, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
Total relevant funding to Central Nervous System - Not Including Brain for this search: $6,167,563
|